General anxiety, depression, and physical health in relation to symptoms of heart-focused anxiety- a cross sectional study among patients living with the risk of serious arrhythmias and sudden cardiac death

Health and Quality of Life Outcomes

Volumn 9, Issue , 2011, Pages

  Hamang, Anniken ^a,b   Eide, Geir E ^a,b   Rokne, Berit ^a   Nordin, Karin ^a,c   Øyen, Nina ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Anxiety; Depression; Heart focused anxiety; Hypertrophic cardiomyopathy; Long qt syndrome; Physical health

Indexed keywords

ADULT; AGE; ANXIETY; ARTICLE; CARDIAC ANXIETY; CARDIAC ANXIETY QUESTIONNAIRE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; GENDER; HEALTH STATUS; HEART ARRHYTHMIA; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; NORWAY; QUESTIONNAIRE; SHORT FORM 36; SUDDEN DEATH; SYMPTOMATOLOGY; ANXIETY DISORDER; ATTENTION; AVOIDANCE BEHAVIOR; FEAR; GENETICS; MIDDLE AGED; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR;

ANXIETY DISORDERS; ATTENTION; AVOIDANCE LEARNING; CARDIOMYOPATHY, HYPERTROPHIC; CROSS-SECTIONAL STUDIES; DEATH, SUDDEN, CARDIAC; DEPRESSIVE DISORDER; FEAR; FEMALE; HEALTH STATUS; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; NORWAY; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 81055150405     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-9-100     Document Type: Article

References (34)

1. Crotti L, Celano G, Dagradi F, Schwartz PJ. Congenital long QT syndrome. Orphanet J Rare Dis 2008, 3:18. 10.1186/1750-1172-3-18, 2474834, 18606002.
2. Elliott P, Spirito P. Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice. Heart 2008, 94:1269-1275.
3. Vincent GM. The Long QT and Brugada syndromes: causes of unexpected syncope and sudden cardiac death in children and young adults. Semin Pediatr Neurol 2005, 12:15-24. 10.1016/j.spen.2004.11.008, 15929461.
4. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002, 287:1308-1320. 10.1001/jama.287.10.1308, 11886323.
5. Khan IA, Win MT, Bali AJ, Vasavada BC, Sacchi TJ. Torsades de pointes: a case with multiple variables. Am J Emerg Med 1999, 17:80-85. 10.1016/S0735-6757(99)90025-6, 9928709.
6. Khan IA. Long QT syndrome: diagnosis and management. Am Heart J 2002, 143:7-14. 10.1067/mhj.2002.120295, 11773906.
7. Maron BJ. Sudden death in young athletes. N Engl J Med 2003, 349:1064-1075. 10.1056/NEJMra022783, 12968091.
8. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 2006, 27:2099-2140.
9. Michels M, Soliman OI, Phefferkorn J, Hoedemaekers YM, Kofflard MJ, Dooijes D, Majoor-Krakauer D, Ten Cate FJ. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers. Eur Heart J 2009,
10. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999, 99:529-533.
11. Christiaans I, van Langen IM, Birnie E, Bonsel GJ, Wilde AA, Smets EM. Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. Am J Med Genet A 2009, 149A:602-612. 10.1002/ajmg.a.32710, 19253387.
12. Hendriks KS, Hendriks MM, Birnie E, Grosfeld FJ, Wilde AA, van den Bout J, Smets EMA, van Tintelen JP, ten Kroode HFJ, van Langen IM. Familial disease with a risk of sudden death: a longitudinal study of the psychological consequences of predictive testing for long QT syndrome. Heart Rhythm 2008, 5:719-724. 10.1016/j.hrthm.2008.01.032, 18452877.
13. Mularczyk E, Decruyenaere M, Denayer L, Evers-Kiebooms G. A theoretical psychological perspective on predictive testing for late onset hereditary diseases. Genet Couns 2007, 18:367-378.
14. Hendriks KS, Grosfeld FJ, Wilde AA, van den Bout J, van Langen IM, van Tintelen JP, ten Kroode HFJ. High distress in parents whose children undergo predictive testing for long QT syndrome. Community Genet 2005, 8:103-113. 10.1159/000084778, 15925886.
15. Hendriks KS, Grosfeld FJ, van Tintelen JP, van Langen IM, Wilde AA, van den Bout J, ten Kroode HFJ. Can parents adjust to the idea that their child is at risk for a sudden death?: Psychological impact of risk for long QT syndrome. Am J Med Genet A 2005, 138A:107-112. 10.1002/ajmg.a.30861, 16149070.
16. Cox S, O'Donoghue AC, McKenna WJ, Steptoe A. Health related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy. Heart 1997, 78:182-187. 484901, 9326995.
17. Eifert GH, Thompson RN, Zvolensky MJ, Edwards K, Frazer NL, Haddad JW, Davig J. The cardiac anxiety questionnaire: development and preliminary validity. Behav Res Ther 2000, 38:1039-1053. 10.1016/S0005-7967(99)00132-1, 11004742.
18. Carmin CN, Wiegartz PS, Hoff JA, Kondos GT. Cardiac anxiety in patients self-referred for electron beam tomography. J Behav Med 2003, 26:67-80. 10.1023/A:1021747106450, 12690947.
19. Eifert GH, Hodson SE, Tracey DR, Seville JL, Gunawardane K. Heart-focused anxiety, illness beliefs, and behavioral impairment: comparing healthy heart-anxious patients with cardiac and surgical inpatients. J Behav Med 1996, 19:385-399. 10.1007/BF01904764, 8836828.
20. Hoyer J, Eifert GH, Einsle F, Zimmermann K, Krauss S, Knaut M, Matschke K, Köllner V. Heart-focused anxiety before and after cardiac surgery. J Psychosom Res 2008, 64:291-297. 10.1016/j.jpsychores.2007.09.009, 18291244.
21. Marker CD, Carmin CN, Ownby RL. Cardiac anxiety in people with and without coronary atherosclerosis. Depress Anxiety 2008, 25:824-831. 10.1002/da.20348, 2577372, 17597101.
22. Zvolensky MJ, Eifert GH, Feldner MT, Leen-Feldner E. Heart-focused anxiety and chest pain in postangiography medical patients. J Behav Med 2003, 26:197-209. 10.1023/A:1023456419736, 12845934.
23. Hamang A, Eide GE, Rokne B, Nordin K, Bjorvatn C, Oyen N. Predictors of Heart-Focused Anxiety in Patients Undergoing Genetic Investigation and Counseling of Long QT Syndrome or Hypertrophic Cardiomyopathy: A One Year Follow-up. J Genet Couns 2011,
24. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370. 10.1111/j.1600-0447.1983.tb09716.x, 6880820.
25. Poole NA, Morgan JF. Validity and reliability of the Hospital Anxiety and Depression Scale in a hypertrophic cardiomyopathy clinic: the HADS in a cardiomyopathy population. Gen Hosp Psychiatry 2006, 28:55-58. 10.1016/j.genhosppsych.2005.08.004, 16377366.
26. Ware JE, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998, 51:903-912. 10.1016/S0895-4356(98)00081-X, 9817107.
27. Ware J, Kosinki MA. SF-36 Physical and mental health summary scales: A manual for users of version 1& interpretation guide 2001, Lincoln, RI: QualityMetric Inc, 2.
28. Loge JH, Kaasa S, Hjermstad MJ, Kvien TK. Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol 1998, 51:1069-1076. 10.1016/S0895-4356(98)00098-5, 9817124.
29. Hanssen TA, Nordrehaug JE, Eide GE, Bjelland I, Rokne B. Anxiety and depression after acute myocardial infarction: an 18-month follow-up study with repeated measures and comparison with a reference population. Eur J Cardiovasc Prev Rehabil 2009, 16:651-659. 10.1097/HJR.0b013e32832e4206, 19707149.
30. Holmen J, Midthjell K, Krüger T, Langhammer A, Holmen TL, Bratberg GH, Vatten L, Lund-Larsen PG. The Nord-Trøndelag Health Study 1995-97(HUNT 2): Objectives, contents, methods and participation. Norwegian Journal of Epidemiology 2003, 13:19-32.
31. Eifert GH. Cardiophobia: a paradigmatic behavioural model of heart-focused anxiety and non-anginal chest pain. Behav Res Ther 1992, 30:329-345. 10.1016/0005-7967(92)90045-I, 1616469.
32. Eifert GH, Forsyth JP. Heart-focused and general illness fears in relation to parental medical history and separation experiences. Behav Res Ther 1996, 34:735-739. 10.1016/0005-7967(96)00030-7, 8936756.
33. Eifert GH, Zvolensky MJ, Lejuez CW. Heart-focused anxiety and chest pain: A conceptual and clinical review. Clinical Psychology-Science and Practice 2000, 7:403-417.
34. Lewinsohn PM, Gotlib IH, Lewinsohn M, Seeley JR, Allen NB. Gender differences in anxiety disorders and anxiety symptoms in adolescents. J Abnorm Psychol 1998, 107:109-117.